Celgene Corp. (CELG)

Index:

Nasdaq 100

$ 0.00
   
  • Closing Price Chg:
    $0.00
  • 52 Week High: $0.00
  • 52 Week Low: $0.00
  • Currency: US Dollars
  • Shares Issued: 702.45m
  • Volume: 0

Celgene Corp. Overview

Celgene engages in the discovery, development, and commercialization of therapies designed to treat cancer and immune-inflammatory-related diseases in the United States. It operates in two segments: Human Pharmaceuticals and Stem Cell Therapies.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0%
Div Cover n/a
Op Mrgn 34.0%
ROCE 218.1%
Latest F'cast
P/E n/a
PEG n/a
Pr/Revenue n/a
Pr/Book n/a
Latest F'cast
Revenue 17.7%
PBT 12.0%
EPS 49.9%
DPS n/a

Celgene Corp. Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-14 7,563.80 2,327.40 249.00¢ 44.9 1.1 +42% n/a 0.0%
31-Dec-15 9,161.10 2,023.50 202.00¢ 59.3 n/a -19% n/a 0.0%
31-Dec-16 11,185.00 2,372.00 257.00¢ 45.0 1.7 +27% n/a 0.0%
31-Dec-17 12,973.00 4,314.00 377.00¢ 27.7 0.6 +47% n/a 0.0%
31-Dec-18 15,265.00 4,832.00 565.00¢ 11.3 0.2 +50% n/a 0.0%

Celgene Corp. ShareCast News

Bristol Myers acquires Celgene in $74bn pharma d... 03-Jan-2019 ShareCast
Juno Therapeutics surges on Celgene deal 22-Jan-2018 ShareCast
Trump calls on drug giants to boost US productio... 31-Jan-2017 ShareCast

Celgene Corp. Top Newspaper Links

For Biotech, a Tax Break Spells Hope 10-Dec-2008 New York Times
Celgene to buy Pharmion 19-Nov-2007 LA Times
Celgene to Acquire Pharmion 19-Nov-2007 New York Times

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Forecast figures based on normalised accounts.

 

Celgene Corp. Market Data

Currency US Dollars
Share Price $ 0.00
Closing Price Change $ 0.00
% Change 0.00 %
52 Week High $0.00
52 Week Low $0.00
Volume 0
Shares Issued 702.45m

Trades for --2024

Time Volume / Share Price
0 @ $0.00

Top of Page